INVESTOR RELATIONS

Stock price

NYSEVAR

$3.2B
FY 2020 REVENUES
$484M
FY 2020 CFFO
$3.3B
FY 2020 Oncology Orders
$3.91
FY 2020 NON-GAAP EPS
13%
R&D GROWTH in FY 2020

$3.2B
FY 2020 REVENUES
$484M
FY 2020 CFFO
$3.3B
FY 2020 Oncology Orders
$3.91
FY 2020 NON-GAAP EPS
13%
R&D GROWTH in FY 2020

Press Releases

Mar 2, 2021

Varian (NYSE: VAR) today announced that Chief Executive Officer Dow Wilson, after more than 16 years with the Company, will retire upon the successful completion of the proposed combination of...

Feb 24, 2021

CTSI Oncology Solutions, a Varian Company, to Provide Technology-Enabled Services for Radiation Oncology at CHRISTUS Health

CTSI Oncology Solutions, a Varian (NYSE: VAR) company that provides oncology services for healthcare providers worldwide, has entered into a long-term, multi-year agreement with CHRISTUS Health, a...

Feb 18, 2021

Varian Becomes First Medical Technology Company Joining the Cancer Drug Development Forum

Varian (NYSE: VAR) announced it has joined the Cancer Drug Development Forum (CDDF) as an industry partner. This makes Varian the first medical technology company to join CDDF, the leading...

Feb 4, 2021

Varian Installs World's First ProBeam® 360° Proton Therapy System at Penn Medicine Lancaster General Health

Varian (NYSE: VAR) has started the installation of the cyclotron and gantry for its ProBeam® 360° single-room proton therapy system at Penn Medicine Lancaster General Health's Ann B. Barshinger...

View all press releases

Upcoming Events

No events to display

View all events

Past Events

First Quarter FY2021 Earnings Results

Tuesday, January 26, 2021

1:10pm PST

In light of the pending transaction with Siemens Healthineers, Varian will not be hosting a conference call for its first quarter of fiscal year 2021 earnings.

Fourth Quarter FY2020 Earnings Results

Tuesday, October 27, 2020

2:15pm PDT

In light of the pending transaction with Siemens Healthineers, Varian will not be hosting a conference call for its fourth quarter of fiscal year 2020 earnings.

Virtual Special Meeting of Stockholders

Thursday, October 15, 2020

9:00am PDT

Third Quarter FY2020 Earnings Results Conference Call

Wednesday, August 5, 2020

1:30pm PDT

Canceled Third Quarter Conference Call in Light of Pending Transaction with Siemens Healthineers

View more events

Quarterly Results

Q4 FY20 Earnings Results

Press Release
Presentation
10-K

View all quarterly results